Market closedNon-fractional
Augmedix/AUGX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Augmedix
Augmedix Inc is engaged in ambulatory/clinical/hospital segments of the U.S. patient care services market with products that address medical note documentation needs. The company's products cater to large and small healthcare organizations but can also be adopted by individual practitioners. The company products extract data from natural clinician-patient conversations and convert it in real time to medical notes, which are seamlessly transferred to the electronic health record (EHR). The company's revenues consist of service fees charged to its customers to subscribe to the company's remote medical documentation and clinical support products.
Ticker
AUGX
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Technology
Headquarters
San Francisco, United States
Employees
1,430
Website
www.augmedix.com
Augmedix Metrics
BasicAdvanced
$112M
Market cap
-
P/E ratio
-$0.43
EPS
0.06
Beta
-
Dividend rate
Price and volume
Market cap
$112M
Beta
0.06
Financial strength
Current ratio
2.038
Quick ratio
1.928
Long term debt to equity
93.948
Total debt to equity
144.496
Interest coverage (TTM)
-8.16%
Management effectiveness
Return on assets (TTM)
-27.11%
Return on equity (TTM)
-280.05%
Valuation
Price to revenue (TTM)
2.23
Price to book
6.26
Price to tangible book (TTM)
6.26
Price to free cash flow (TTM)
-5.182
Growth
Revenue change (TTM)
45.04%
Earnings per share change (TTM)
-32.42%
3-year revenue growth (CAGR)
41.19%
3-year earnings per share growth (CAGR)
-28.42%
What the Analysts think about Augmedix
Analyst Ratings
Majority rating from 6 analysts.
Augmedix Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$13M
6.35%
Net income
-$6.4M
45.45%
Profit margin
-47.76%
36.77%
Augmedix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.12
-$0.10
-$0.09
-$0.26
-
Expected
-$0.13
-$0.12
-$0.10
-$0.13
-$0.14
Surprise
-7.69%
-14.89%
-10.00%
94.03%
-
Augmedix News
AllArticlesVideos
Shareholder Alert: Ademi LLP investigates whether Augmedix, Inc. has obtained a Fair Price for its Public Shareholders
PRNewsWire·1 week ago
Augmedix to Join Forces with Commure
GlobeNewsWire·1 week ago
Emergency Services Inc. Partners with Augmedix to Introduce Generative AI Solution That Relieves Clinician Burnout in Emergency Departments
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Augmedix stock?
Augmedix (AUGX) has a market cap of $112M as of July 27, 2024.
What is the P/E ratio for Augmedix stock?
The price to earnings (P/E) ratio for Augmedix (AUGX) stock is 0 as of July 27, 2024.
Does Augmedix stock pay dividends?
No, Augmedix (AUGX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Augmedix dividend payment date?
Augmedix (AUGX) stock does not pay dividends to its shareholders.
What is the beta indicator for Augmedix?
Augmedix (AUGX) has a beta rating of 0.06. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Augmedix stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.